ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IOVA Iovance Biotherapeutics Inc

11.695
-0.105 (-0.89%)
Last Updated: 11:41:46
Delayed by 15 minutes

Iovance Biotherapeutics Financial Summary

The current IOVA market cap is 3.27B. The company's latest EPS is USD -1.5898 and P/E is -7.36.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000238k469k
Operating Income -100.4M-107.04M-110.86M-110.09M-118.36M
Net Income -99.62M-105.32M-107.37M-106.53M-113.76M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00001.19M
Operating Income -206.87M-261.94M-342.7M-398.88M-460.56M
Net Income -197.56M-259.58M-342.25M-395.89M-444.04M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 545.92M663.98M824.77M757.29M852.32M
Total Liabilities 152.19M164.34M157.89M178.72M178.31M
Total Equity 393.74M499.64M666.88M578.57M674.01M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 344.66M768.46M777.33M663.98M780.35M
Total Liabilities 45.68M111.96M155.67M164.34M195.74M
Total Equity 298.97M656.5M621.66M499.64M584.61M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -215.09M-292.76M-99.82M-193.77M-277.85M
Investing 255.99M256.46M153.4M-3.38M-82.4M
Financing -425k190.15M258.17M259.2M462M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -158.89M-205.13M-227.94M-292.76M-361.82M
Investing 90.03M-317.85M132k256.46M-155.24M
Financing 6.13M576.42M239.27M190.15M462.96M
Market Cap 3.27B
Price to Earnings Ratio -7.36
Price to Sales Ratio 2.72k
Price to Cash Ratio 28.45
Price to Book Ratio 5.59
Dividend Yield -

Share Statistics

Shares Outstanding 279.31M
Average Volume (1 week) 4.63M
Average Volume (1 Month) 4.75M
52 Week Change 100.26%
52 Week High 18.33
52 Week Low 3.21
Spread (Intraday) 0.01 (0.09%)

Company Info

Company Name Iovance Biotherapeutics Inc
Address 2140 s dupont hwy
camden, delaware 19934
Website https://www.iovance.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock